Opus Genetics, Inc.

Ownership Transactions Reported by 18 Insiders

Symbol
IRD on Nasdaq
Industry
Pharmaceutical Preparations
Location
8 Davis Drive, Suite 220, Durham, NC

Insiders trading volume in the past year

Opus Genetics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Foundation Fighting Blindness Retinal Degeneration Fund Director, Other* $4.53M Oct 22, 2024
George Magrath Chief Executive Officer, Director $1.52M +$208K +15.8% Mar 24, 2025
Cam Gallagher Director $991K Mar 24, 2025
Richard J. Rodgers Director $422K Jun 11, 2024
Benjamin R. Yerxa President, Director $337K +$9.83K +3% Nov 21, 2024
Jay Pepose Director $319K Jun 11, 2024
Ronil A. Patel Chief Business Officer $296K Jan 10, 2024
Susan Benton Director $247K Jun 11, 2024
Nirav S. Jhaveri Chief Financial Officer $223K Mar 13, 2025
Bernhard Hoffmann SVP of Corp. Dev. $213K Mar 13, 2025
James Manuso Director $178K Jan 2, 2025
Mina Sooch President and CEO, Director $163K Jan 10, 2023
Sean Ainsworth Director $156K Jun 11, 2024
Ashwath Jayagopal Chief Scientific & Dev. Ofc. $145K +$6.18K +4.46% Mar 13, 2025
Rabourn Amy Zaremba SVP of Finance $131K Mar 13, 2025
Jean Bennett Director $131K Jan 2, 2025
Joseph K. Schachle Chief Operating Officer $62.7K Mar 13, 2025
Adrienne L. Graves Director Oct 22, 2024

Recent Insider Transactions by Companies or Individuals for Opus Genetics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.